JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrea Garatti
Tiziano Colombo
Ettore Vitali
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garatti, A.
Right arrow Articles by Vitali, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garatti, A.
Right arrow Articles by Vitali, E.
Related Collections
Right arrow Minimally invasive surgery
Right arrow Valve disease

J Thorac Cardiovasc Surg 2006;132:989-990
© 2006 The American Association for Thoracic Surgery

Letter to the Editor

Placement of the Impella Recover LD microaxial blood pump through a bioprosthesis is technically feasible

Andrea Garatti, MD, Tiziano Colombo, MD, Ettore Vitali, MD

"A. De Gasperis" Cardiac surgery Division, Niguarda Ca' Granda Hospital, Piazza Ospedale Maggiore 3, Milan 20162, Italy

(Email: agaratti@tiscali.it).

The first 20% of the full text of this article appears below.

To the Editor:

We read with great interest the article of Strauch and colleagues1Go regarding their experience with Impella Recover LD support for postcardiotomy low-output syndrome in a patient undergoing aortic valve replacement with a bioprosthesis. In our initial experience2Go we reported the use of the Impella Recover LD to support a patient with valvular cardiomyopathy who underwent conventional mitral valve repair and aortic valve replacement with a 21 mm Carpentier-Edwards bioprosthesis. Despite maximal inotropic support (epinephrine dose, 0.2 µg/kg–1/min–1), the patient could not be weaned from extracorporeal circulation, with hypotension, increased filling pressure (left atrial pressure, 28 mm Hg), and oliguria . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.